Search

Author/Creator Janelidze, Shorena

4. A biomarker profile of elevated CSF p‐tau with normal tau PET is associated with increased tau accumulation rates on PET in early Alzheimer's disease. (20th December 2022)

Authors:
Groot, Colin; Smith, Ruben; Stomrud, Erik; Binette, Alexa Pichet; Leuzy, Antoine; Wuestefeld, Anika; Wisse, Laura EM; Palmqvist, Sebastian; Janelidze, Shorena; Strandberg, Olof; Ossenkoppele, Rik; Hansson, Oskar
Journal:
Alzheimer's & dementia
Issue:
Volume 18(2022)Supplement 6
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. A biomarker profile of elevated CSF p‐tau with normal tau PET is associated with increased tau accumulation rates on PET in early Alzheimer's disease. (20th December 2022)

Authors:
Groot, Colin; Smith, Ruben; Stomrud, Erik; Binette, Alexa Pichet; Leuzy, Antoine; Wuestefeld, Anika; Wisse, Laura EM; Palmqvist, Sebastian; Janelidze, Shorena; Strandberg, Olof; Ossenkoppele, Rik; Hansson, Oskar
Journal:
Alzheimer's & dementia
Issue:
Volume 18(2022)Supplement 1
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Ability of tau‐PET, phospho‐tau217, NfL and cortical thickness to predict short‐term cognitive decline in early symptomatic Alzheimer's disease. (December 2021)

Authors:
Smith, Ruben; Cullen, Nicholas; Leuzy, Antoine; Janelidze, Shorena; Palmqvist, Sebastian; Dage, Jeffrey L; Borroni, Edilio; Klein, Gregory; Ossenkoppele, Rik; Mattsson‐Carlgren, Niklas; Stomrud, Erik; Hansson, Oskar
Journal:
Alzheimer's & dementia
Issue:
Volume 17(2021)Supplement 4
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Ability of tau‐PET, phospho‐tau217, NfL and cortical thickness to predict short‐term cognitive decline in early symptomatic Alzheimer's disease. Issue 4 (1st February 2022)

Authors:
Smith, Ruben; Cullen, Nicholas; Leuzy, Antoine; Janelidze, Shorena; Palmqvist, Sebastian; Dage, Jeffrey L; Borroni, Edilio; Klein, Gregory; Ossenkoppele, Rik; Mattsson‐Carlgren, Niklas; Stomrud, Erik; Hansson, Oskar
Journal:
Alzheimer's & dementia
Issue:
Volume 17:Issue 4(2021)Supplement
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that are impacted by APOE ε4, sex and age but not pathology: Biomarkers (non‐neuroimaging): Novel biomarkers. (7th December 2020)

Authors:
Ayton, Scott; Janelidze, Shorena; Roberts, Blaine R.; Palmqvist, Sebastian; Kalinowski, Pawel; Diouf, Ibrahima; Belaidi, Abdel Ali; Stomrud, Erik; Bush, Ashley I; Hansson, Oskar
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 5
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Acute phase markers in CSF reveal inflammatory changes in Alzheimer's disease that intersect with pathology, APOE ε4, sex and age. (March 2021)

Authors:
Ayton, Scott; Janelidze, Shorena; Roberts, Blaine; Palmqvist, Sebastian; Kalinowski, Pawel; Diouf, Ibrahima; Belaidi, Abdel A.; Stomrud, Erik; Bush, Ashley I.; Hansson, Oskar
Journal:
Progress in neurobiology
Issue:
Volume 198(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Amyloid blood biomarker detects Alzheimer's disease. Issue 5 (6th April 2018)

Authors:
Nabers, Andreas; Perna, Laura; Lange, Julia; Mons, Ute; Schartner, Jonas; Güldenhaupt, Jörn; Saum, Kai‐Uwe; Janelidze, Shorena; Holleczek, Bernd; Rujescu, Dan; Hansson, Oskar; Gerwert, Klaus; Brenner, Hermann
Journal:
EMBO molecular medicine
Issue:
Volume 10:Issue 5(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗